VEGFA and wet macular degeneration: Current vascular endothelial growth factor (VEGF) inhibitors are very effective in limiting the detrimental effects of neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) (1–3).